跳至主要内容
临床试验/ACTRN12621001316897
ACTRN12621001316897已完成未知

Acceptance Commitment Therapy (ACT) for distress associated with inflammatory bowel disease: A feasibility trial of the ACTforIBD program

Deakin University0 个研究点目标入组 120 人开始时间: 2021年9月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of IBD: Crohn’s disease, ulcerative colitis or indeterminate colitis established by a health professional using standard criteria (evidence can include a letter from a doctor, results of endoscopy or any other medical document confirming the diagnosis);
  • Distress: scores 16-29 on K10 (screening for distress will take place after consent has been obtained);
  • Age: 18 years and older;
  • Language: Able to read and write in English;
  • Residence: Live in Australia or New Zealand;
  • Other: Access to the internet

排除标准

  • No distress (scores <16 on K10);
  • Severe distress (scores 30-50 on K10) as it is anticipated that these participants would require a more intensive therapeutic approach before benefiting from the current intervention.

研究者

相似试验

Acceptance Commitment Therapy (ACT) for distress... | 临床试验